ArticleInternational journal of pharmaceutics: X2025
Synthesis of pH-sensitive hydrogel beads for controlled delivery of ketorolac tromethamine: computational evaluation and in vivo pharmacokinetic study.
Article in International journal of pharmaceutics: X, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Tannic Acid-Based Multilayers Anchoring Anthocyanin-Loaded Mesoporous Silica Microcapsules: A Synergistic Hydrogel System for Ameliorating DSS-Induced Colitis.Journal of food science · 2026Article
- Development of an injectable thermosensitive hydrogel depot system for controlled and sustained subcutaneous drug delivery.International journal of pharmaceutics: X · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The current study aimed to develop pH-responsive hydrogel beads based on sodium alginate (SA) and acrylic acid (Aa), crosslinked in the presence of calcium chloride, for the controlled delivery of ketorolac tromethamine. The hydrogel beads were fabricated using the ionic gelation technique and subsequently characterized for their structural properties, surface morphology, and thermal stability. Additional investigations, including sol-gel analysis, drug loading efficiency, and drug quantification, were conducted to evaluate the physicochemical attributes of the prepared beads. Furthermore, Monte Carlo simulations using the adsorption locator module in Materials Studio were conducted to investigate the adsorption behavior of ketorolac on the SA/Aa hydrogel beads. The negative adsorption energy obtained from the simulations suggested that the interaction between the drug and polymer was both spontaneous and exothermic, indicating a thermodynamically favorable binding mechanism. The pH responsiveness of the beads was evaluated through swelling and drug release studies under different pH conditions (pH 1.2 and 7.4). The results indicated markedly significant swelling and drug release at pH 7.4 as compared to 1.2, thereby confirming the pH-responsive behavior of the formulated beads. The toxicity of the hydrogel beads was evaluated using the Hen's Egg Test on Chorioallantoic Membrane (HET-CAM), which revealed no signs of irritation or toxicity. An in vivo pharmacokinetic study in rabbits further demonstrated that the drug-loaded hydrogel beads achieved higher plasma concentrations of ketorolac tromethamine compared to the drug solution, supporting their potential for improved bioavailability. Hence, the developed SA/Aa-based hydrogel beads exhibited favorable physicochemical, biocompatibility, and pharmacokinetic profiles, making them promising candidates for controlled drug delivery systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.